Literature DB >> 22361226

Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM.

Takahisa Gono, Kouhei Miyake, Yasushi Kawaguchi, Hirotaka Kaneko, Mikiko Shinozaki, Hisashi Yamanaka.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22361226     DOI： 10.1093/rheumatology/kes012

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  13 in total

1.  Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis.

Authors:  Takao Nagashima; Yasuyuki Kamata; Masahiro Iwamoto; Hitoaki Okazaki; Noriyoshi Fukushima; Seiji Minota
Journal:  Rheumatol Int       Date:  2019-02-21       Impact factor: 2.631

2.  Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.

Authors:  Atsushi Tanaka; Hiroshi Tsukamoto; Hiroki Mitoma; Chikako Kiyohara; Naoyasu Ueda; Masahiro Ayano; Shun-ichiro Ohta; Yasutaka Kimoto; Mitsuteru Akahoshi; Yojiro Arinobu; Hiroaki Niiro; Yoshifumi Tada; Takahiko Horiuchi; Koichi Akashi
Journal:  Arthritis Res Ther       Date:  2015-02-10       Impact factor: 5.156

Review 3.  Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies.

Authors:  Hidenaga Kawasumi; Takahisa Gono; Yasushi Kawaguchi; Hisashi Yamanaka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-07-23

4.  Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study.

Authors:  Katsuhiro Oda; Takuya Kotani; Tohru Takeuchi; Takaaki Ishida; Takeshi Shoda; Kentaro Isoda; Shuzo Yoshida; Yasuichiro Nishimura; Shigeki Makino
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

Review 5.  Management of Myositis-Associated Interstitial Lung Disease.

Authors:  Tomoyuki Fujisawa
Journal:  Medicina (Kaunas)       Date:  2021-04-03       Impact factor: 2.430

Review 6.  Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System.

Authors:  Huifang Hu; Hang Yang; Yi Liu; Bing Yan
Journal:  Front Med (Lausanne)       Date:  2022-01-24

7.  Increased Serum LIGHT Levels Correlate with Disease Progression and Severity of Interstitial Pneumonia in Patients with Dermatomyositis: A Case Control Study.

Authors:  Takuya Kotani; Tohru Takeuchi; Takaaki Ishida; Ryota Masutani; Kentaro Isoda; Kenichiro Hata; Shuzo Yoshida; Shigeki Makino; Toshiaki Hanafusa
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

8.  IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis/dermatomyositis.

Authors:  Hidenaga Kawasumi; Takahisa Gono; Yasushi Kawaguchi; Hirotaka Kaneko; Yasuhiro Katsumata; Masanori Hanaoka; Sayuri Kataoka; Hisashi Yamanaka
Journal:  Biomed Res Int       Date:  2014-04-01       Impact factor: 3.411

9.  Anti-MDA5 Positive Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease and Correlation between Serum Ferritin Level and Treatment Response.

Authors:  Daniela Noa Zohar; Lior Seluk; Hagith Yonath; Yehuda Shoenfeld; Shaye Kivity
Journal:  Mediterr J Rheumatol       Date:  2020-03-31

10.  Increased Levels of Soluble CD206 Associated with Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis.

Authors:  Ya-Wen Shen; Ya-Mei Zhang; Zhen-Guo Huang; Guo-Chun Wang; Qing-Lin Peng
Journal:  Mediators Inflamm       Date:  2020-10-26       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.